Cargando…
The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
Treatment with β-blockers is the main strategy for managing patients with heart failure and reduced ejection fraction because of their ability to reverse the neurohumoral effects of the sympathetic nervous system, with consequent prognostic and symptomatic benefits. However, to date, they are underu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468030/ https://www.ncbi.nlm.nih.gov/pubmed/34564119 http://dx.doi.org/10.3390/jcdd8090101 |